ES2449571T3 - Derivados de amino-piperidina como inhibidores de CETP - Google Patents
Derivados de amino-piperidina como inhibidores de CETP Download PDFInfo
- Publication number
- ES2449571T3 ES2449571T3 ES07786158.1T ES07786158T ES2449571T3 ES 2449571 T3 ES2449571 T3 ES 2449571T3 ES 07786158 T ES07786158 T ES 07786158T ES 2449571 T3 ES2449571 T3 ES 2449571T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- amino
- cycloalkyl
- aryl
- mmol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06117541 | 2006-07-20 | ||
EP06117541 | 2006-07-20 | ||
US88705807P | 2007-01-29 | 2007-01-29 | |
US887058P | 2007-01-29 | ||
PCT/EP2007/006384 WO2008009435A1 (en) | 2006-07-20 | 2007-07-18 | Amino-piperidine derivatives as cetp inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2449571T3 true ES2449571T3 (es) | 2014-03-20 |
Family
ID=37680601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES07786158.1T Active ES2449571T3 (es) | 2006-07-20 | 2007-07-18 | Derivados de amino-piperidina como inhibidores de CETP |
Country Status (13)
Country | Link |
---|---|
KR (1) | KR20120034774A (da) |
CN (1) | CN101490035B (da) |
BR (1) | BRPI0714516A2 (da) |
DK (1) | DK2049517T3 (da) |
ES (1) | ES2449571T3 (da) |
MY (1) | MY153262A (da) |
NZ (1) | NZ573439A (da) |
PT (1) | PT2049517E (da) |
RU (1) | RU2442782C2 (da) |
SG (1) | SG173378A1 (da) |
SI (1) | SI2049517T1 (da) |
UA (1) | UA96942C2 (da) |
ZA (1) | ZA200810008B (da) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112898257B (zh) * | 2021-03-12 | 2023-01-24 | 天津理工大学 | 一种水溶性香豆素衍生物内盐的合成方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2719311B1 (fr) * | 1994-03-18 | 1998-06-26 | Sanofi Sa | Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic. |
US6140342A (en) * | 1998-09-17 | 2000-10-31 | Pfizer Inc. | Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines |
-
2007
- 2007-07-18 PT PT77861581T patent/PT2049517E/pt unknown
- 2007-07-18 SG SG201105146-3A patent/SG173378A1/en unknown
- 2007-07-18 CN CN2007800273100A patent/CN101490035B/zh not_active Expired - Fee Related
- 2007-07-18 RU RU2009105763/04A patent/RU2442782C2/ru not_active IP Right Cessation
- 2007-07-18 KR KR1020127002833A patent/KR20120034774A/ko not_active Application Discontinuation
- 2007-07-18 DK DK07786158.1T patent/DK2049517T3/da active
- 2007-07-18 UA UAA200813674A patent/UA96942C2/uk unknown
- 2007-07-18 ES ES07786158.1T patent/ES2449571T3/es active Active
- 2007-07-18 SI SI200731423T patent/SI2049517T1/sl unknown
- 2007-07-18 NZ NZ573439A patent/NZ573439A/en not_active IP Right Cessation
- 2007-07-18 MY MYPI20090048A patent/MY153262A/en unknown
- 2007-07-18 BR BRPI0714516-0A patent/BRPI0714516A2/pt not_active Application Discontinuation
-
2008
- 2008-11-25 ZA ZA200810008A patent/ZA200810008B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
ZA200810008B (en) | 2009-11-25 |
SG173378A1 (en) | 2011-08-29 |
MY153262A (en) | 2015-01-29 |
RU2009105763A (ru) | 2010-08-27 |
KR20120034774A (ko) | 2012-04-12 |
DK2049517T3 (da) | 2014-03-03 |
CN101490035A (zh) | 2009-07-22 |
PT2049517E (pt) | 2014-03-10 |
SI2049517T1 (sl) | 2014-04-30 |
NZ573439A (en) | 2012-02-24 |
RU2442782C2 (ru) | 2012-02-20 |
BRPI0714516A2 (pt) | 2014-07-08 |
CN101490035B (zh) | 2013-02-13 |
UA96942C2 (uk) | 2011-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2007276433B2 (en) | Amino-piperidine derivatives as CETP inhibitors | |
US8420641B2 (en) | Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives | |
JP5421282B2 (ja) | 高脂血症または動脈硬化症のような疾患の処置に有用なcetp阻害剤としての1,2−二置換−4−ベンジルアミノ−ピロリジン誘導体 | |
US20090181929A1 (en) | Organic compounds | |
US20100076021A1 (en) | Organic Compounds | |
US20100041705A1 (en) | Organic Compounds | |
ES2449571T3 (es) | Derivados de amino-piperidina como inhibidores de CETP | |
AU2012202172B2 (en) | 4-benzylamino-1-carboxyacyl-piperidine derivatives as CETP inhibitors useful for the treatment of diseases such as hyperlipidemia or arteriosclerosis |